by Frank M. Szaba, and Stephen T. Smiley

Slides:



Advertisements
Similar presentations
by Peter Ruf, and Horst Lindhofer
Advertisements

An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma by Stephen D. Gillies, Yan Lan, Steven Williams,
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen–specific IgE production by stimulation of IL-12 production in mice  Shinji.
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice by Robert G. Newman,
Volume 133, Issue 5, Pages (November 2007)
by Björn Rabe, Athena Chalaris, Ulrike May, Georg H
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo
A critical role for TNFα in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles by Teresa Mateo, Yafa Naim Abu Nabah,
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
by Norman Nausch, Ioanna E
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
by Éric Aubin, Réal Lemieux, and Renée Bazin
Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation  Roshi Afshar, PhD, James P. Strassner, BS, Edward.
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy by Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew Flies, Sarah.
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
Lung dendritic cells induce TH17 cells that produce TH2 cytokines, express GATA-3, and promote airway inflammation  Marianne Raymond, PhD, Vu Quang Van,
Volume 9, Issue 3, Pages (March 2004)
Volume 34, Issue 2, Pages (February 2011)
Antigen-Specific Peripheral Tolerance Induced by Topical Application of NF-κB Decoy Oligodeoxynucleotide  Iwao Isomura, Kunio Tsujimura, Akimichi Morita 
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing.
Volume 42, Issue 2, Pages (February 2015)
IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions  Sayaka Shibata, Yayoi Tada, Yoshihide Asano, Koichi Yanaba, Makoto.
Volume 11, Issue 4, Pages (October 1999)
Volume 19, Issue 4, Pages (April 2017)
Volume 33, Issue 2, Pages (August 2010)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Volume 11, Issue 5, Pages (November 1999)
Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti- CD3–Conditioned Recipients  Wei He, Jeremy J. Racine, Heather F.
Volume 146, Issue 6, Pages (September 2011)
Volume 6, Issue 4, Pages (April 1997)
Volume 140, Issue 2, Pages e4 (February 2011)
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Activating anti-CD40 antibody partially mitigates the deficit in CTL generation and accumulation elicited by immunization with F/T 4T1-OVA cells. Activating.
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Volume 38, Issue 2, Pages (February 2013)
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-α Pathway of Systemic and Cutaneous Inflammation  Arndt J. Schottelius,
Topical Imiquimod Treatment Prevents UV-Light Induced Loss of Contact Hypersensitivity and Immune Tolerance  Thomas H. Thatcher, Irina Luzina, Rita Fishelevich,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Volume 29, Issue 6, Pages (December 2008)
Volume 33, Issue 2, Pages (August 2010)
Volume 6, Issue 6, Pages (December 2009)
Production and Pharmacologic Modulation of the Granulocyte-Associated Allergic Responses to Ovalbumin in Murine Skin Models Induced by Injecting Ovalbumin-
Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice by Hui Zhou, Meihong Deng, Yingjie Liu, Chenxuan.
Volume 19, Issue 3, Pages (September 2003)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 26, Issue 4, Pages (April 2007)
Eric A Butz, Michael J Bevan  Immunity 
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 31, Issue 4, Pages (October 2009)
Arp2/3-mediated formation of nuclear actin networks is essential for CD4+ T cell effector functions. Arp2/3-mediated formation of nuclear actin networks.
Susceptibility to allergic lung disease regulated by recall responses of dual-receptor memory T cells∗  Mark A. Aronica, MD, Shadi Swaidani, MS, Yan H.
Volume 32, Issue 1, Pages (January 2010)
Volume 11, Issue 3, Pages (September 1999)
Volume 4, Issue 3, Pages (September 2008)
Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo  Donald C. Foster, Ralf Paus  Journal.
Volume 28, Issue 5, Pages (May 2008)
Volume 20, Issue 3, Pages (March 2012)
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 25, Issue 4, Pages (April 2017)
Volume 38, Issue 3, Pages (March 2013)
Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo  Gabriele Müller, Anke Müller  Journal of Investigative.
Volume 60, Issue 6, Pages (December 2001)
Hapten-Specific Tolerance Promoted by Calcitonin Gene-Related Peptide
Volume 4, Issue 5, Pages (May 1996)
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo by Holger Hackstein, Timucin Taner,
Volume 15, Issue 2, Pages (February 2007)
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

by Frank M. Szaba, and Stephen T. Smiley Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo by Frank M. Szaba, and Stephen T. Smiley Blood Volume 99(3):1053-1059 February 1, 2002 ©2002 by American Society of Hematology

The activation of inflammation-elicited peritoneal macrophages is thrombin dependent in vivo.(A) The activation-induced adhesion of peritoneal macrophages by antigen-specific Th1 cells is thrombin dependent. The activation of inflammation-elicited peritoneal macrophages is thrombin dependent in vivo.(A) The activation-induced adhesion of peritoneal macrophages by antigen-specific Th1 cells is thrombin dependent. OT-II transgenic T-cell receptor Th1 effector cells were adoptively transferred to C57Bl/6 mice that had been primed with TG (3 mL intraperitoneally) 3 days earlier. The next day, Ova peptide (50 μg intraperitoneally) or PBS vehicle (200 μL) were administered, and 5 hours later peritoneal exudate cells were harvested and macrophages were enumerated. Where indicated, mice received Refludan (2 mg/kg intraperitoneally) at the time of Ova administration. The data depicts the averages and standard deviations of groups of 3 mice. Th1 cells induced antigen-specific macrophage activation (P < .01), which was suppressed by Refludan (P = .02). This experiment was replicated twice. (B) The activation-induced adhesion of peritoneal macrophages by LPS is thrombin dependent. Peritoneal macrophages were elicited with TG (3 mL intraperitoneally). Four days later, LPS (1 μg intraperitoneally) or vehicle control (200 μL PBS) were administered, and macrophage numbers in peritoneal exudates were determined 5 hours later. Where indicated, mice also received Relfudan (20 mg/kg intraperitoneally) at the time of LPS administration. The data depicts the averages and standard deviations of groups of 5 mice. LPS induced macrophage activation (P < .0001) that was suppressed by Refludan (P < .0001). This experiment has been replicated 4 times. Frank M. Szaba, and Stephen T. Smiley Blood 2002;99:1053-1059 ©2002 by American Society of Hematology

Purified thrombin activates inflammation-elicited peritoneal macrophages in vivo.(A) Dose response to thrombin. Purified thrombin activates inflammation-elicited peritoneal macrophages in vivo.(A) Dose response to thrombin. Four days after TG-stimulated macrophage elicitation (3 mL intraperitoneally), the indicated dosages of purified thrombin were administered, and macrophage numbers in peritoneal exudates were determined after 2.5 hours. (B) Kinetics of macrophage activation in response to thrombin and LPS. Four days after TG-stimulated macrophage elicitation, mice received intraperitoneal injections of thrombin (20 U, ●), LPS (1 μg, ■), or vehicle control (200 μL PBS, ○), and macrophage numbers in peritoneal exudates were determined at the indicated times. For A and B, the data represent the averages and standard deviations of 4 animals per group. Frank M. Szaba, and Stephen T. Smiley Blood 2002;99:1053-1059 ©2002 by American Society of Hematology

The activation of inflammation-elicited peritoneal macrophages is not PAR-1 dependent.PAR-1–deficient (−/−, ■) and littermate control (+/−, ▪) mice were compared, using the assays described in Figure 1. The activation of inflammation-elicited peritoneal macrophages is not PAR-1 dependent.PAR-1–deficient (−/−, ■) and littermate control (+/−, ▪) mice were compared, using the assays described in Figure 1. The data represent the averages and standard deviations of 5 animals per group. Neither TG-induced macrophage recruitment nor macrophage activation were significantly impaired in PAR-1–deficient mice. Frank M. Szaba, and Stephen T. Smiley Blood 2002;99:1053-1059 ©2002 by American Society of Hematology

The activation of inflammation-elicited peritoneal macrophages is fibrinogen dependent.Fibrinogen-deficient (−/−, ■) and littermate control (+/−, ▪) mice were compared, using the assays described in Figure 1. The activation of inflammation-elicited peritoneal macrophages is fibrinogen dependent.Fibrinogen-deficient (−/−, ■) and littermate control (+/−, ▪) mice were compared, using the assays described in Figure 1. The data represent the averages and standard deviations of 5 animals per group. TG-induced recruitment of inflammatory macrophages was not significantly impaired in fibrinogen-deficient mice, but macrophage activation was significantly diminished in the absence of fibrinogen (Th1/Ova, P < .002; LPS, P < .002). This experiment was repeated 3 times. Frank M. Szaba, and Stephen T. Smiley Blood 2002;99:1053-1059 ©2002 by American Society of Hematology

Thrombin stimulates fibrinogen-dependent cytokine and chemokine production in vivo.Four days after TG administration, wild-type (+/+, ▪) or fibrinogen-deficient (−/−, ■) mice received intraperitoneal injections of thrombin (20 U). Thrombin stimulates fibrinogen-dependent cytokine and chemokine production in vivo.Four days after TG administration, wild-type (+/+, ▪) or fibrinogen-deficient (−/−, ■) mice received intraperitoneal injections of thrombin (20 U). Macrophage numbers in peritoneal exudates were determined after 5 hours (left panel). Thrombin-stimulated macrophage activation was fibrinogen dependent (P < .001). Examination of the exudate fluid by ELISA revealed that thrombin also stimulated increases in peritoneal levels of MCP-1 (middle panel, P < .005) and IL-6 (right panel,P < .001) that were fibrinogen dependent (P < .005 and P < .001, respectively). The data represent averages and standard deviations of 4 animals per group. We repeated this experiment twice. Frank M. Szaba, and Stephen T. Smiley Blood 2002;99:1053-1059 ©2002 by American Society of Hematology